Corrigendum to “Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation”: [Annals of Oncology 28 (2017):2503–2510, (S0923753419349440), (10.1093/annonc/mdx340)]

H. Takamatsu*, N. Takezako, J. Zheng, M. Moorhead, V. E.H. Carlton, K. A. Kong, R. Murata, S. Ito, T. Miyamoto, K. Yokoyama, K. Matsue, T. Sato, T. Kurokawa, H. Yagi, Y. Terasaki, K. Ohata, M. Matsumoto, T. Yoshida, M. Faham, S. Nakao

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

The authors regret that in the original publication the labelling of Figures 2 and 4 was incorrect. The y-axes of Figure 2D and 2F, and Figure 4B and 4F should read “Percent OS” not “Percent PFS”. The authors would like to apologise for any inconvenience caused.

Original languageEnglish
Pages (from-to)322
Number of pages1
JournalAnnals of Oncology
Volume34
Issue number3
DOIs
StatePublished - 2023/03

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint

Dive into the research topics of 'Corrigendum to “Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation”: [Annals of Oncology 28 (2017):2503–2510, (S0923753419349440), (10.1093/annonc/mdx340)]'. Together they form a unique fingerprint.

Cite this